IssuerAnnouncementDetailsV2Portlet
Actions
Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 798.91 | 811.84 | -1.592 | 724.15 | 10.323 |
| Gross Profit (Loss) | 174.98 | 180.62 | -3.122 | 139.9 | 25.075 |
| Operational Profit (Loss) | 69.71 | 81.61 | -14.581 | 44.61 | 56.265 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 57.93 | 82.12 | -29.456 | 38.41 | 50.82 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 57.93 | 82.12 | -29.456 | 38.41 | 50.82 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 1,523.06 | 1,512.86 | 0.674 |
| Gross Profit (Loss) | 314.87 | 356.75 | -11.739 |
| Operational Profit (Loss) | 114.32 | 158.59 | -27.914 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 96.34 | 154.32 | -37.571 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 96.34 | 154.32 | -37.571 |
| Total Shareholders Equity (after Deducting Minority Equity) | 3,194.81 | 3,034.45 | 5.284 |
| Profit (Loss) per Share | 0.42 | 0.67 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenue in 2Q26 was 799M or 1.6% lower from prior year, however, excluding the non-recurring Hajj contract recognized in 2Q25, revenue grew 7.6% year on year, reflecting the underlying growth across the Group's operating platform. The Group served 4% more patients in 2Q26 compared with 2Q25, with surgical procedures up 26%, supporting continued growth in higher-acuity activity. The Group's New Business revenue, comprising DSFH Riyadh and DSFH Madinah, grew by 93% year on year, supported by the deepening of DSFH Riyadh's service-line offering and the full-quarter contribution of DSFH Madinah. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Although the number of patients served grew since last year fueled by the growth in New Business, net profit decreased mainly due to: - Higher revenue from New Business - Lower revenue from Home Healthcare and Mature Business - Lower volumes in the Group's Operate and Manage agreements - Higher depreciation and amortization at DSFH Madinah - One-off transaction costs related to the acquisitions and new projects - Pre-operating expenses of Medical Center Al Awali in Makkah, which is now operational as of August 2026 - Higher net finance costs reflecting the higher average debt balances as well as the interest on DSFH Madinah borrowings previously treated as pre-operating and were accordingly capitalized. - Costs associated with the two new land leases for the planned medical college in Madinah and the Jizan Hospital project. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | The increase in revenue in 2Q26 compared with 1Q26 was mainly attributable to the absence of holidays (Ramadan and Eid Al Fitr seasonality that affected 1Q26), which increased the effective number of operating days and patients served during the quarter, along with the continued ramp-up of New Business. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | The increase in net profit in 2Q26 compared with 1Q26, was mainly driven by the increased revenues following the Ramadan and Eid Al Fitr holidays that affected 1Q26 patient volumes, which further supported the absorption of the Group's cost base. The net profit improvement was further supported by the narrowing of New Business losses as DSFH Riyadh and DSFH Madinah sustained their ramp-up. |
| The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is | Revenue in 1H26 was 1,523M or 0.7% higher from prior year, however, excluding the non-recurring Hajj contract recognized in 2Q25, revenue grew 5.5% year on year, reflecting the underlying growth across the Group's operating platform. The Group served 3% more patients in 1H26 compared with 1H25, with surgical procedures up 22%, supporting continued growth in higher-acuity activity. The Group's New Business revenue, comprising DSFH Riyadh and DSFH Madinah, grew by 86% year on year, supported by the deepening of DSFH Riyadh's service-line offering and the full-quarter contribution of DSFH Madinah. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Although the number of patients served grew since last year fueled by the growth in New Business, net profit decreased mainly due to: - Higher revenue from New Business - Lower revenue from Home Healthcare and Mature Business - Lower volumes in the Group's Operate and Manage agreements - Higher depreciation and amortization at DSFH Madinah - One-off transaction costs related to the acquisitions and new projects - Pre-operating expenses of Medical Center Al Awali in Makkah, which is now operational as of August 2026 - Higher net finance costs reflecting the higher average debt balances as well as the interest on DSFH Madinah borrowings previously treated as pre-operating and were accordingly capitalized. - Costs associated with the two new land leases for the planned medical college in Madinah and the Jizan Hospital project. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | NA |
| Reclassification of Comparison Items | Certain comparative figures have been reclassified, wherever considered necessary, for the purpose of comparison and better presentation. |
| Additional Information | NA |
| Attached Documents |  |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 38.6
Net Change 0.2 (+0.52%)
Value Traded (Sar) 6,558,161.98
Volume Traded 168,545
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions